NEW YORK ( TheStreet) -- Merck (NYSE: MRK) hit a new 52-week high Tuesday as it is currently trading at $39.47, above its previous 52-week high of $39.46 with 13 million shares traded as of 3:50 p.m. ET. Average volume has been 14.1 million shares over the past 30 days. Merck has a market cap of $117.02 billion and is part of the health care sector and drugs industry. Shares are up 2.1% year to date as of the close of trading on Monday. Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company has a P/E ratio of 19, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter